Skip to main content
logo
Clearside Biomedical, Inc. (CLSDQ)
OTCMKTS · Delayed Price · Currency is USD
0.2490
0.00 (0.00%)
Inactive · Last trade price on Jul 13, 2026

Clearside Biomedical Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
3.331.668.231.3329.587.89
Revenue Growth
-56.78%-79.77%519.89%-95.51%274.65%263.28%
Gross Profit
2.931.527.871.1229.587.89
Operating Income
-22.96-28.88-24.84-30.28-0.63-17.94
Net Income
-26-34.35-32.49-32.950.38-18.21
Earnings Per Share
-5.05-6.98-7.88-8.210.10-5.87
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
6.820.0228.9248.2630.4417.29
Total Debt
61.6152.474335.260.681.98
Net Cash (Debt)
-54.81-32.45-14.081329.7615.31
Net Cash Growth
----56.33%94.43%-5.43%
Net Cash Per Share
-10.64-6.60-3.423.247.454.94

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
-21.29-24.7-18.14-13.37-10.73-13.12
Capital Expenditures
-0.45-0.98-1.78-0.25--0.06
Free Cash Flow
-21.75-25.68-19.91-13.61-10.73-13.18
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Gross Margin
88.07%91.05%95.68%84.63%100.00%100.00%
Operating Margin
-689.76%-1735.70%-302.02%-2281.61%-2.12%-227.20%
Pretax Margin
-759.42%-2064.42%-394.91%-2482.82%1.27%-230.68%
Profit Margin
-780.89%-2064.42%-394.91%-2482.82%1.27%-230.68%
FCF Margin
-653.23%-1542.97%-242.06%-1025.70%-36.29%-166.90%

Valuation
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingAug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PE Ratio
----436.39-
PS Ratio
5.5143.308.8850.805.5516.78